Literature DB >> 28188959

Amniotic fluid embolism: Pathophysiology from the perspective of pathology.

Naoaki Tamura1, Mustari Farhana1, Tomoaki Oda1, Hiroaki Itoh1, Naohiro Kanayama1.   

Abstract

Amniotic fluid embolism (AFE) is recognized as a type of syndrome characterized by the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy (DIC), occurring during labor, delivery, or immediately postpartum, caused by the inflow of amniotic components into the maternal circulation. AFE is a rare condition but one of the most serious obstetrical complications, resulting in a high mortality rate among pregnant women. Despite earlier recognition and intensive critical management, we often encounter patients who unfortunately do not recover from the exacerbation of AFE-related conditions. A major concern is that there are no effective evidence-based therapies for AFE, because its pathophysiology is still not well understood. This article reviewed AFE, focusing on the pathology and currently proposed pathophysiology.
© 2017 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  amniotic fluid embolism; anaphylactoid reaction; disseminated intravascular coagulopathy; postpartum acute myometritis; postpartum hemorrhage; uterine atony

Mesh:

Year:  2017        PMID: 28188959     DOI: 10.1111/jog.13284

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  9 in total

1.  Fatal amniotic fluid embolism: incidence, risk factors and influence on perinatal outcome.

Authors:  Chengya Zhu; Dong Xu; Qiong Luo
Journal:  Arch Gynecol Obstet       Date:  2022-04-09       Impact factor: 2.344

2.  Summary of clinically diagnosed amniotic fluid embolism cases in Korea and disagreement with 4 criteria proposed for research purpose.

Authors:  Jin-Ha Kim; Hyun-Joo Seol; Won Joon Seong; Hyun-Mee Ryu; Jin-Gon Bae; Joon Seok Hong; Jeong In Yang; Ji-Hee Sung; Suk-Joo Choi; Soo-Young Oh; Cheong-Rae Roh
Journal:  Obstet Gynecol Sci       Date:  2020-12-28

3.  Fibrinogen may aid in the early differentiation between amniotic fluid embolism and postpartum haemorrhage: a retrospective chart review.

Authors:  Shigetaka Matsunaga; Hiroko Masuko; Yasushi Takai; Naohiro Kanayama; Hiroyuki Seki
Journal:  Sci Rep       Date:  2021-04-16       Impact factor: 4.379

4.  The Role of Extra Corporeal Membrane Oxygenation in Amniotic Fluid Embolism: A Case Report and Literature Review.

Authors:  Shalini Durgam; Munish Sharma; Rahul Dadhwal; Abhay Vakil; Salim Surani
Journal:  Cureus       Date:  2021-02-26

5.  McConnell's Sign in a Patient with Amniotic Fluid Embolism and Severe Right Ventricular Dysfunction.

Authors:  Rana Hassan; Andre Ferland; T Lee-Ann Hawkins; Robert J H Miller
Journal:  CASE (Phila)       Date:  2021-10-16

6.  Effect of intraoperative cell rescue on bleeding related indexes after cesarean section.

Authors:  Yu-Fang Yu; Yong-Dong Cao
Journal:  World J Clin Cases       Date:  2022-03-16       Impact factor: 1.337

Review 7.  Maternal death analysis based on data from the nationwide registration system in Japan (2010-2018).

Authors:  Tomoko Wakasa; Hatsue Ishibashi-Ueda; Makoto Takeuchi
Journal:  Pathol Int       Date:  2021-02-09       Impact factor: 2.534

8.  Successful treatment of amniotic fluid embolism complicated by disseminated intravascular coagulation with rivaroxaban: A case report.

Authors:  Hai-Di Wu; Zi-Kai Song; Hong-Yan Cao; Xiao-Yan Xu; Ming-Long Tang; Shuo Yang; Yang Liu; Ling Qin
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

9.  Consumptive Coagulopathy Involving Amniotic Fluid Embolism: The Importance of Earlier Assessments for Interventions in Critical Care.

Authors:  Tomoaki Oda; Naoaki Tamura; Rui Ide; Toshiya Itoh; Yoshimasa Horikoshi; Masako Matsumoto; Megumi Narumi; Yukiko Kohmura-Kobayashi; Naomi Furuta-Isomura; Chizuko Yaguchi; Toshiyuki Uchida; Kazunao Suzuki; Hiroaki Itoh; Naohiro Kanayama
Journal:  Crit Care Med       Date:  2020-12       Impact factor: 9.296

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.